Email this article 
Chronic obstructive pulmonary disease and associated illnesses
- Authors: Chuchalin AG1
-
Affiliations:
- Issue: Vol 80, No 8 (2008)
- Pages: 45-50
- Section: Editorial
- URL: https://ter-arkhiv.ru/0040-3660/article/view/30228
- ID: 30228
Cite item
Full Text
Full Text
Хроническая обструктивная болезнь легких и сопутствующие заболевания. -×
References
- Buch P., Friberg J., Scharling Н. et al. Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. Eur. Respir. J. 2003; 21 (6): 1012-1016.
- Fuso L., Incalzi R. A., Pistelli R. et al. Predicting mortality of patients for acutely exacerbated chronic obstructive pulmonary disease. Am. J. Med. 1995; 98 (3): 272-277.
- Kleiger R. E. Long-term electrocardiographic monitoring of ambulatory patients with COPD. Chest 1974; 65: 483-488.
- Shih H. Т., Webb C. R., Conway W. A. et al. Frequency and significance of cardiac arrhythmias in COPD. Chest 1988; 94 (1): 44-48.
- Bittar G, Friedman H. S. The arrhythmogenicity of theophylline. A multivariate analysis of clinical determinants. Chest 1991; 99 (6): 1-10.
- Salpeter S. R., Ormiston Т. M., Salpeter E. E. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest 2004; 125 (6): 2309-2321.
- Incalzi R. A., Pistelli R., Cocchi A. et al. Cardiac arrhythmias and left ventricular function in respiratory failure from chronic COPD. Chest 1990; 97 (5): 1092-1097.
- Cheong Т. H., Magder S., Shapiro S. et al. Cardiac arrhythmias during exercise in severe chronic obstructive pulmonary disease. Chest 1990; 97 (4): 793-797.
- Salpeter S., Ormiston Т., Salpeter E. Cardioselective beta-blocker use in patients with reversible airway disease. Cochrane Database Syst. Rev. 2001; (2): CD002992.
- Ind P. W., Dixon С. M., Fuller R. W., Barnes P. J. Anticholinergic blockade of beta-blocker-induced bronchoconstriction. Am. Rev. Respir. Dis. 1989; 139 (6): 1390-1394.
- Behar S., Panosh A., Reicher-Reiss H. et al. Prevalence and prognosis of COPD among 5839 consecutive patients with acute myocardila infarction. Sprint Study Group. Am. J. Med. 1992; 93 (6): 637-641.
- Man S. F. COPD as a risk factor for cardiovascular morbidity and mortality. Proc. Am. Thorax Soc. 2005; 2 (1): 8-11.
- Jousilahti P., Vartianen E., Puska P. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet 1996; 348 (9027): 567-572.
- Triboulloy C, Rosinaru D., Mahjoub H. et al. Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study. Eur. Heart J. 2007; 5.
- Dahl M., Vestbo J., Lange P. et al. C-reactive protein as a predictor of prognosis in COPD. Am. J. Respir. Crit. Med. 2007; 175: 250-255.
- van Vliet M., Spruit M. A., Verleden G. et al. Hypogonadism, quadriceps, weakness, and exercise intolerance in COPD. Am. J. Respir. Crit. Care Med. 2005; 172: 105-111.
